NCT05597111 is a clinical trial of DHA levels of blood and cervical mucus in Polycystic Ovary Syndrome, sponsored by Recep Tayyip Erdogan University Training and Research Hospital.

Who is sponsoring NCT05597111?

NCT05597111 is sponsored by Recep Tayyip Erdogan University Training and Research Hospital.

What drugs are being tested in NCT05597111?

Interventions in NCT05597111: DHA levels of blood and cervical mucus.

What condition does NCT05597111 study?

NCT05597111 studies Polycystic Ovary Syndrome.

Is NCT05597111 still recruiting?

NCT05597111 is currently status unknown. Last updated 27 October 2022.

Last reviewed 2022-10-27 · How we verify

NCT05597111

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Docosahexaenoic (DHA) Values in Patients With Polycystic Ovary Syndrome (PCOS)

Status unknown Last updated 27 October 2022

What this trial tests

trial testing DHA levels of blood and cervical mucus in Polycystic Ovary Syndrome in 138 participants. Status unknown.

Timeline

1 November 2022

Primary endpoint
1 February 2023

1 February 2023

Quick facts

Lead sponsor	Recep Tayyip Erdogan University Training and Research Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	138
Start date	1 November 2022
Primary completion	1 February 2023
Estimated completion	1 February 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

DHA levels of blood and cervical mucus

Conditions studied

Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →

Sponsor

Recep Tayyip Erdogan University Training and Research Hospital

Who can join

Adults 18 to 40, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although PCOS has been known for many years, its etiology and treatment are not clearly known. The prevalence of PCOS varies between populations. It is a familial endocrinolpathology with a chronic course, multifactorial, polygenic feature seen with an average prevalence of 6-8% in women in the reproductive period.Chronic inflammation is involved in the pathophysiology of many chronic diseases. PCOS, which is a proinflammatory condition, has been associated with insulin resistance and hyperandrogenism in previous studies. Omega-3 fatty acids have anti-inflammatory, anti-thrombotic, anti-arrhythmic properties, reducing lipid levels such as serum triglyceride and LDL cholesterol, and having positive effects on the immune system. Therefore, their deficiencies include fatigue, joint pain, frequent infections, etc. is seen. Omega-6 fatty acids have the opposite effect. DHA is a member of the omega-3 fatty acids family. Dietary components play an important role in chronic inflammation. According to our literature review, there is no study that detects docosahexaenoic acid (DHA) levels in blood and cervical mucus samples in patients with PCOS. We think that we will contribute to the diagnosis and treatment processes of PCOS patients by detecting DHA levels in this study. In this study, we aim to compare the values of docosahexaenoic acid (DHA) in serum and cervical mucus samples in patients with polycystic ovary syndrome with the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting

Other Recep Tayyip Erdogan University Training and Research Hospital trials

Trials by the same sponsor.

NCT07427095 — The Relationship Between Ultra-Processed Food Consumption and Oral Health · not yet recruiting
NCT07427069 — Chronic Kidney Disease Associated Diet · not yet recruiting
NCT07462104 — Metabolic Syndrome Associated Diet · not yet recruiting
NCT07354815 — Metabolic Syndrome-Associated Periodontal Inflammatory Surface Area · not yet recruiting
NCT07287540 — Anti-inflammatory Nutrition on the Outcomes of Non-surgical Periodontal Therapy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05597111 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Recep Tayyip Erdogan University Training and Research Hospital
Last refreshed: 27 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05597111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing